| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NUP62 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | SRSF10 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | TAF1A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | UXT | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | MTDH | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | EIF4G1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | PARP10 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | CD3EAP | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | MYCL | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | TBRG1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
